South San Francisco, Calif., Jan. 30, 2026 (GLOBE NEWSWIRE) -- The California Institute for Regenerative Medicine (CIRM) has approved a new funding program to accelerate therapies for rare diseases, ...
Last week, the California Institute for Regenerative Medicine (CIRM) approved a new funding program aimed at accelerating gene therapies for rare diseases by moving away from traditional approaches ...
Jonathan Thomas, PhD, JD has been appointed CIRM’s President and CEO · GlobeNewswire Inc. Jonathan Thomas, PhD, JD Jonathan Thomas, PhD, JD has been appointed CIRM’s President and CEO · GlobeNewswire ...
Insight provides an in-depth look at health care issues in and affecting California. Have a story suggestion? Let us know. Nearly 11 years after California voters approved Proposition 71 — the ...
WOODBRIDGE, Conn.--(BUSINESS WIRE)--Cure Rare Disease (CRD) announced it has been awarded a $5.69 million grant from the California Institute for Regenerative Medicine (CIRM) to advance the ...
EMERYVILLE, Calif.--(BUSINESS WIRE)--Eureka Therapeutics, Inc., a clinical-stage biotechnology company developing novel T-cell therapies to treat cancer, today announced that the California Institute ...
Board approved 19 awards worth $67 million and $4.8 million to bring Dr. Coffey from London to California. The California Institute for Regenerative Medicine (CIRM) approved funding for 19 awards ...
PASADENA, Calif., April 28, 2026 /PRNewswire/ -- AcuraStem, a biotechnology company advancing treatments for amyotrophic lateral sclerosis (ALS), frontotemporal dementia (FTD), and other ...
Evangelina Padilla Vaccaro of Corona is the new face of stem cell science in California. Born with “bubble baby” disease that deprived her of a functioning immune system, she was cured with stem cell ...
Anyone who cares about the advance of medical science and about the promise of biotechnology should be dismayed by how badly the California stem cell agency has handled its latest conflict-of-interest ...
San Francisco, CA, United States, Sept. 27, 2024 (GLOBE NEWSWIRE) -- The California Institute for Regenerative Medicine (CIRM), one of the world's largest institutes dedicated to regenerative medicine ...
SAN DIEGO, April 04, 2025 (GLOBE NEWSWIRE) -- Tr1X, Inc. (pronounced “Trix”), a clinical-stage biopharmaceutical company developing first-in-class allogeneic engineered Treg and CAR-Treg cell ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results